首页|线粒体动力相关蛋白1与动脉粥样硬化研究进展

线粒体动力相关蛋白1与动脉粥样硬化研究进展

扫码查看
线粒体动力学是指线粒体通过分裂和融合维持线粒体网络的动态平衡并为细胞提供能量,多种因素诱导下引发的线粒体动力学失衡,尤其是线粒体分裂异常与动脉粥样硬化(AS)进展密切相关。而动力相关蛋白1(Drp1)是介导线粒体分裂的最关键蛋白,Drp1在AS中表达增加与内皮细胞衰老、血管平滑肌细胞增殖和迁移及向成骨样细胞转化、巨噬细胞参与的胆固醇外流及炎症反应等AS相关病理因素相互影响,加速疾病进程。此外,Drp1的抑制剂及部分中药提取物被证明依赖于Drp1途径减缓AS进程。现就Drp1的结构与活性调控、其在AS进展中的关键作用及靶向Drp1治疗AS的研究现状加以阐述。
Dynamin-Related Protein 1 and Atherosclerosis
Mitochondrial dynamics refers to mitochondrial fission and fusion in order to maintain the dynamic balance of the mitochondrial network and provide energy to the cell.The advancement of atherosclerosis(AS)is directly linked to an imbalance in mitochondrial dynamics caused by a variety of causes,particularly abnormal mitochondrial fission.Dynamic related protein 1(Drp1)is the most critical protein that mediates mitochondrial division.The increased expression of Drp1 in AS interacts with pathological factors related to AS,such as endothelial cell senescence,proliferation and migration of vascular smooth muscle cells,and transformation to osteoblast-like cells,macrophage-involved cholesterol efflux and inflammation,thereby accelerating the disease progression.In addition,inhibitors of Drp1 and some herbal extracts have been shown to be dependent on the Drp1 pathway to decelerate AS progression.This article elaborates on the structure and activity regulation of Drp1,its key role in the progression of AS,and the current research status of targeted Drp1 therapy for AS.

AtherosclerosisMitochondrionDynamin-related protein 1

刘小雨、庞树朝、江杨杨、王丽欣

展开 >

天津中医药大学第一附属医院国家中医针灸临床医学研究中心,天津 300193

动脉粥样硬化 线粒体 动力相关蛋白1

天津市教委科研计划项目北京中医药大学孙思邈研究院2021年度中医药科研计划资助项目天津中医药大学第一附属医院"拓新工程"基金科研项目

2022KJ167SSMYJY-2-2021-04ZD202109

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(1)
  • 40